您的位置: 首页 > 农业专利 > 详情页

Oral administration of the pharmaceutical composition for the treatment of irritable bowel syndrome, containing the intestinal peristalsis regulator, which prevents the delay of the delay
专利权人:
ЭлЭлПи (GB);ПОУЗИ ВИЖНЭРИ СОЛЮШНЗ
发明人:
БЕРНАРДО ЭСКУДЕРО Роберто (MX),САВУАР ВИЛЬБЕФ Джон Клод
申请号:
RU2013127270/15
公开号:
RU2013127270A
申请日:
2011.11.15
申请国别(地区):
RU
年份:
2014
代理人:
摘要:
1. A pharmaceutical composition or composition adapted for oral administration, in the form of a tablet, coated tablets or capsules for preventing or treating intestinal disorders, wherein the composition consists of a regulator of intestinal motility, an agent that prevents gas retention, a digestive enzyme, a binder, a diluent , absorbent, disintegrant, lubricant and glidant. 2. The pharmaceutical composition according to claim 1, wherein the intestinal motility regulator is selected from the group consisting of trimebutin, fenoverin, mebeverin, dicycloverin, ethyl bromide, alosetron, tegaserod, loperamide, phloroglucinol, trimethylfloroglucinol, butylscopolamine and parveverin. 3. The pharmaceutical composition according to claim 2, wherein the intestinal motility regulator is trimebutin and its pharmaceutically acceptable salts. The pharmaceutical composition according to claim 2, wherein the intestinal motility regulator is phenoverine and its pharmaceutically acceptable salts. The pharmaceutical composition according to claim 2, wherein the intestinal motility regulator is mebeverin and its pharmaceutically acceptable salts. The pharmaceutical composition according to claim 2, wherein the intestinal motility regulator is dicycloverin and its pharmaceutically acceptable salts. The pharmaceutical composition according to claim 2, wherein the intestinal motility regulator is ethyl bromide and its pharmaceutically acceptable salts. The pharmaceutical composition according to claim 2, wherein the intestinal motility regulator is alosetron and its pharmaceutically acceptable salts. Pharmaceutical1. Фармацевтическая композиция или состав, адаптированный для перорального введения, в форме таблетки, покрытой оболочкой таблетки или капсулы для предотвращения или лечения кишечных нарушений, где состав состоит из регулятора перистальтики кишечника, средства, которое предотвращает задержку газов, пищеварительного фермента, связующего средства, разбавителя, абсорбирующего с
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充